Want to see MEDP full AI Analyst Report?
Total Valuation
Medpace Holdings has a market cap or net worth of $16.83B. The enterprise value is $14.76B.
Market Cap$16.83B
Enterprise Value$14.76B
Share Statistics
Medpace Holdings has 27,911,655 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,911,655
Owned by Insiders18.74%
Owned by Institutions0.79%
Financial Efficiency
Medpace Holdings’s return on equity (ROE) is 0.98 and return on invested capital (ROIC) is 67.94%.
Return on Equity (ROE)0.98
Return on Assets (ROA)0.23
Return on Invested Capital (ROIC)67.94%
Return on Capital Employed (ROCE)0.85
Revenue Per Employee389.27K
Profits Per Employee69.40K
Employee Count6,500
Asset Turnover1.28
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medpace Holdings is 34.7. Medpace Holdings’s PEG ratio is 1.82.
PE Ratio34.7
PS Ratio6.40
PB Ratio35.29
Price to FCF23.76
Price to Operating Cash Flow22.73
PEG Ratio1.82
Income Statement
In the last 12 months, Medpace Holdings had revenue of 2.53B and earned 451.12M in profits. Earnings per share was 15.64.
Revenue2.53B
Gross Profit760.62M
Operating Income534.93M
Pretax Income542.38M
Net Income451.12M
EBITDA570.50M
Earnings Per Share (EPS)15.64
Cash Flow
In the last 12 months, operating cash flow was 752.66M and capital expenditures -19.15M, giving a free cash flow of 733.51M billion.
Operating Cash Flow752.66M
Free Cash Flow733.51M
Free Cash Flow per Share26.28
Dividends & Yields
Medpace Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.99
52-Week Price Change16.50%
50-Day Moving Average601.46
200-Day Moving Average524.57
Relative Strength Index (RSI)48.78
Average Volume (3m)231.77K
Important Dates
Medpace Holdings upcoming earnings date is Oct 21, 2026, After Close (Confirmed).
Last Earnings DateJul 22, 2026
Next Earnings DateOct 21, 2026
Ex-Dividend Date―
Financial Position
Medpace Holdings as a current ratio of 0.74, with Debt / Equity ratio of 33.22%
Current Ratio0.74
Quick Ratio0.74
Debt to Market Cap0.00
Net Debt to EBITDA-0.63
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medpace Holdings has paid 91.25M in taxes.
Income Tax91.25M
Effective Tax Rate0.17
Enterprise Valuation
Medpace Holdings EV to EBITDA ratio is 27.77, with an EV/FCF ratio of 23.23.
EV to Sales6.26
EV to EBITDA27.77
EV to Free Cash Flow23.23
EV to Operating Cash Flow22.21
Balance Sheet
Medpace Holdings has $502.69M in cash and marketable securities with $144.11M in debt, giving a net cash position of $358.58M billion.
Cash & Marketable Securities$502.69M
Total Debt$144.11M
Net Cash$358.58M
Net Cash Per Share$12.85
Tangible Book Value Per Share-$8.21
Margins
Gross margin is 28.76%, with operating margin of 21.14%, and net profit margin of 17.83%.
Gross Margin28.76%
Operating Margin21.14%
Pretax Margin21.44%
Net Profit Margin17.83%
EBITDA Margin22.55%
EBIT Margin21.44%
Analyst Forecast
The average price target for Medpace Holdings is $612.10, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$612.10
Price Target Upside-0.32% Downside
Analyst ConsensusHold
Analyst Count12
Revenue Growth Forecast24.67%
EPS Growth Forecast25.88%